Menorrhagia: Multimedia

References

1. HALLBERG L, NILSSON L. DETERMINATION OF MENSTRUAL BLOOD LOSS. Scand J Clin Lab Invest. 1964;16:244-8. [Medline].

2. Goldrath MH. Hysteroscopic endometrial ablation. Obstet Gynecol Clin North Am. Sep 1995;22(3):559-72. [Medline].

3. Fraser IS, Warner P, Marantos PA. Estimating menstrual blood loss in women with normal and excessive menstrual fluid volume. Obstet Gynecol. Nov 2001;98(5 Pt 1):806-14. [Medline].

4. Warner PE, Critchley HO, Lumsden MA, Campbell-Brown M, Douglas A, Murray GD. Menorrhagia I: measured blood loss, clinical features, and outcome in women with heavy periods: a survey with follow-up data. Am J Obstet Gynecol. May 2004;190(5):1216-23. [Medline].

5. Lentz GM. Abnormal Uterine Bleeding. In: Katz VL, Lentz GM, Lobo RA, Gershenson DM. Comprehensive Gynecology. 5th. Philadelphia, PA: Mosby; 2007:915-932.

6. Wright RC. Hysterectomy: past, present, and future. Obstet Gynecol. Apr 1969;33(4):560-3. [Medline].

7. Wilansky DL, Greisman B. Early hypothyroidism in patients with menorrhagia. Am J Obstet Gynecol. Mar 1989;160(3):673-7. [Medline].

8. Glasser MH, Zimmerman JD. The HydroThermAblator system for management of menorrhagia in women with submucous myomas: 12- to 20-month follow-up. J Am Assoc Gynecol Laparosc. Nov 2003;10(4):521-7. [Medline].

9. Collins J, Schlesselman H. Hormone Replacement Therapy and Endometrial Cancer. In: Lobo R. Treatment of the Postmenopausal Woman. Philadelphia, PA: Lippincott, Williams & Wilkins; 1999.

10. [Guideline] James AH, Kouides PA, Abdul-Kadir R, Edlund M, Federici AB, Halimeh S, et al. Von Willebrand disease and other bleeding disorders in women: Consensus on diagnosis and management from an international expert panel. Am J Obstet Gynecol. May 28 2009;[Medline].

11. Kadir RA, Economides DL, Sabin CA, et al. Frequency of inherited bleeding disorders in women with menorrhagia. Lancet. Feb 14 1998;351(9101):485-9. [Medline].

12. Dodson MG. Use of transvaginal ultrasound in diagnosing the etiology of menometrorrhagia. J Reprod Med. May 1994;39(5):362-72. [Medline].

13. Dijkhuizen FP, Mol BW, Brölmann HA, Heintz AP. The accuracy of endometrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasia: a meta-analysis. Cancer. Oct 15 2000;89(8):1765-72. [Medline].

14. Shaw RW. Assessment of medical treatments for menorrhagia. Br J Obstet Gynaecol. Jul 1994;101 Suppl 11:15-8. [Medline].

15. Jurema M, Zacur H. Menorrhagia. UpToDate. Available at http://www.uptodateonline.com/online/content/topic.do?topicKey=gen_gyne/4741&selectedTitle=1~138&source=search_result. Accessed March 29, 2009.

16. Fraser IS, McCarron G. Randomized trial of 2 hormonal and 2 prostaglandin-inhibiting agents in women with a complaint of menorrhagia. Aust N Z J Obstet Gynaecol. Feb 1991;31(1):66-70. [Medline].

17. Andersson JK, Rybo G. Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia. Br J Obstet Gynaecol. Aug 1990;97(8):690-4. [Medline].

18. Rauramo I, Elo I, Istre O. Long-term treatment of menorrhagia with levonorgestrel intrauterine system versus endometrial resection. Obstet Gynecol. Dec 2004;104(6):1314-21. [Medline].

19. Results unpublished, information provided from press release. FDA Approves Intrauterine Device for Heavy Menstrual Bleeding. Available at http://www.prnewswire.com/news-releases/fda-approves-new-indication-for-mirenar-to-treat-heavy-menstrual-bleeding-in-iud-users-63164722.html.

20. DeCherney A, Polan ML. Hysteroscopic management of intrauterine lesions and intractable uterine bleeding. Obstet Gynecol. Mar 1983;61(3):392-7. [Medline].

21. Chullapram T, Song JY, Fraser IS. Medium-term follow-up of women with menorrhagia treated by rollerball endometrial ablation. Obstet Gynecol. Jul 1996;88(1):71-6. [Medline].

22. Meyer WR, Walsh BW, Grainger DA, et al. Thermal balloon and rollerball ablation to treat menorrhagia: a multicenter comparison. Obstet Gynecol. Jul 1998;92(1):98-103. [Medline].

23. Goldrath MH. Evaluation of HydroThermAblator and rollerball endometrial ablation for menorrhagia 3 Years after treatment. J Am Assoc Gynecol Laparosc. Nov 2003;10(4):505-11. [Medline].

24. [Guideline] ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 81, May 2007. Obstet Gynecol. May 2007;109(5):1233-48. [Medline].

25. [Best Evidence] Lethaby A, Hickey M, Garry R. Endometrial destruction techniques for heavy menstrual bleeding. Cochrane Database Syst Rev. Oct 19 2005;CD001501. [Medline]. [Full Text].

26. Learman LA, Summitt RL Jr, Varner RE, Richter HE, Lin F, Ireland CC. Hysterectomy versus expanded medical treatment for abnormal uterine bleeding: clinical outcomes in the medicine or surgery trial. Obstet Gynecol. May 2004;103(5 Pt 1):824-33. [Medline].

27. Showstack J, Lin F, Learman LA, Vittinghoff E, Kuppermann M, Varner RE. Randomized trial of medical treatment versus hysterectomy for abnormal uterine bleeding: resource use in the Medicine or Surgery (Ms) trial. Am J Obstet Gynecol. Feb 2006;194(2):332-8. [Medline].

Further Reading

Keywords

menorrhagia, heavy menses, metrorrhagia, menometrorrhagia, polymenorrhea, dysfunctional uterine bleeding, hysterectomy, heavy menstrual bleeding, dilatation and curettage, transcervical resection of the endometrium, roller-ball endometrial ablation, endometrial laser ablation, uterine balloon therapy, myomectomy, uterine artery embolization, UAE, microwave endometrial ablation alternative, HydroThermAblator, cryoablation,

Contributor Information and Disclosures

Author

Julia A Shaw, MD, MBA, FACOG, Assistant Clinical Professor and Associate Program Director, Department of Obstetrics and Gynecology, Yale School of Medicine; Medical Director, Yale-New Haven Hospital Women's Center
Julia A Shaw, MD, MBA, FACOG is a member of the following medical societies: American Association of Gynecologic Laparoscopists, American College of Obstetricians and Gynecologists, American College of Physician Executives, American Medical Association, and Connecticut State Medical Society
Disclosure: Nothing to disclose.

Coauthor(s)

Howard A Shaw, MD, Associate Professor of Obstetrics and Gynecology, University of Connecticut; Chairman/Director, Residency Program Director, Department of Obstetrics and Gynecology, St Francis Hospital and Medical Center
Howard A Shaw, MD is a member of the following medical societies: American College of Forensic Examiners, American College of Obstetricians and Gynecologists, American College of Physician Executives, American Medical Association, American Society for Colposcopy and Cervical Pathology, American Urogynecologic Society, Association of American Medical Colleges, Association of Professors of Gynecology and Obstetrics, Central Association of Obstetricians and Gynecologists, Connecticut State Medical Society, International Urogynaecology Association, and Southern Medical Association
Disclosure: Merck Honoraria Speaking and teaching; Athena Feminine Technologies Ownership interest Consulting

Medical Editor

Thomas Michael Price, MD, Associate Professor of Reproductive Endocrinology, Director of Reproductive Fellowship Training Program, Duke University Medical Center
Thomas Michael Price, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Obstetricians and Gynecologists, American Society for Reproductive Medicine, Phi Beta Kappa, and Society for Gynecologic Investigation
Disclosure: Clinical Advisors Group Consulting fee Consulting; MEDA Corp Consulting Consulting fee Consulting; Gerson Lehrman Group Advisor  Consulting fee Consulting; Roche/GSK Spokesperson  Consulting fee Consulting; Abbott Pharmaceuticals Grant/research funds PI; Adiana Grant/research funds PI

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

A David Barnes, MD, PhD, MPH, FACOG, Consulting Staff, Department of Obstetrics and Gynecology, Mammoth Hospital (Mammoth Lakes, California), Pioneer Valley Hospital (Salt Lake City, Utah), Warren General Hospital (Warren, Pennsylvania), and Mountain West Hospital (Tooele, Utah)
A David Barnes, MD, PhD, MPH, FACOG is a member of the following medical societies: American College of Forensic Examiners, American College of Obstetricians and Gynecologists, American Medical Association, Association of Military Surgeons of the US, and Utah Medical Association
Disclosure: Nothing to disclose.

CME Editor

Frederick B Gaupp, MD, Consulting Staff, Department of Family Practice, Hancock Medical Center
Frederick B Gaupp, MD is a member of the following medical societies: American Academy of Family Physicians
Disclosure: Nothing to disclose.

Chief Editor

Michel E Rivlin, MD, Professor, Coordinator of Quality Assurance/Quality Improvement, Department of Obstetrics and Gynecology, University of Mississippi School of Medicine
Michel E Rivlin, MD is a member of the following medical societies: American College of Obstetricians and Gynecologists, American Medical Association, Mississippi State Medical Association, and Royal College of Surgeons of Edinburgh
Disclosure: Nothing to disclose.